The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical outcome (CO) evaluation of very old (≥ 80 years) castration resistant prostate cancer (CRPC) patients (pts) treated with docetaxel (DOC): Preliminary results of an Italian multicenter retrospective study (DELPHI study).
Francesca Maines
No relevant relationships to disclose
Salvatore Luca Burgio
No relevant relationships to disclose
Giuseppe Di Lorenzo
No relevant relationships to disclose
Florinda Scognamiglio
No relevant relationships to disclose
Fable Zustovich
No relevant relationships to disclose
Gaetano Facchini
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose
Roberto Bortolus
No relevant relationships to disclose
Giovanni Lo Re
No relevant relationships to disclose
Francesca La Russa
No relevant relationships to disclose
Andrea Bonetti
No relevant relationships to disclose
Caterina Messina
No relevant relationships to disclose
Michele Lodde
No relevant relationships to disclose
Alessandra Perin
No relevant relationships to disclose
Roberto Iacovelli
No relevant relationships to disclose
Giovanni L. Pappagallo
No relevant relationships to disclose
Antonello Veccia
No relevant relationships to disclose
Orazio Caffo
No relevant relationships to disclose
Enzo Galligioni
No relevant relationships to disclose